Coherus Oncology, Inc.CHRSNASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank31
3Y CAGR-40.5%
5Y CAGR-15.7%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-40.5%/yr
vs -0.9%/yr prior
5Y CAGR
-15.7%/yr
Recent deceleration
Acceleration
-39.6pp
Decelerating
Percentile
P31
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
3 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.21 | -65.0% |
| 2024 | 0.60 | -21.2% |
| 2023 | 0.76 | -23.6% |
| 2022 | 1.00 | +62.0% |
| 2021 | 0.62 | +24.5% |
| 2020 | 0.50 | +7.4% |
| 2019 | 0.46 | -55.5% |
| 2018 | 1.04 | +66.2% |
| 2017 | 0.62 | +11.0% |
| 2016 | 0.56 | - |